BOLT BIOTHERAPEUTICS INC (BOLT:NASDAQ)
$5.285 0.155 (3.0214%)
Analysed BOLT BIOTHERAPEUTICS INC (BOLT:NASDAQ) News Sources
Bolt Biotherapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
12-11-2025
yahoo.com
Bolt Biotherapeutics Inc.: Q3 Earnings Snapshot
12-11-2025
yahoo.com
Bolt Biotherapeutics, Inc. (BOLT) Reports Q3 Loss, Beats Revenue Estimates
12-11-2025
yahoo.com
Bolt Biotherapeutics to Participate in Upcoming March Conferences
24-02-2026
yahoo.com
Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Business Update
12-03-2026
yahoo.com
Bolt Biotherapeutics Inc.: Q4 Earnings Snapshot
12-03-2026
yahoo.com
Bolt Biotherapeutics, Inc. (BOLT) Reports Q4 Loss, Tops Revenue Estimates
12-03-2026
yahoo.com
Bolt Metals Corp. Announces Appointment of Chief Financial Officer and Corporate Secretary
09-04-2026
yahoo.com
Bolt Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
12-05-2026
yahoo.com
Bolt Biotherapeutics, Inc. (BOLT) Reports Q1 Loss, Lags Revenue Estimates
12-05-2026
yahoo.com
What is the current price of BOLT BIOTHERAPEUTICS INC (BOLT:NASDAQ)?
The current price of BOLT BIOTHERAPEUTICS INC (BOLT:NASDAQ) is $5.285.
BOLT BIOTHERAPEUTICS INC (BOLT:NASDAQ) absolute price change since previous trading day?
The absolute price change of BOLT BIOTHERAPEUTICS INC (BOLT:NASDAQ) since the previous trading day is $0.155.
BOLT BIOTHERAPEUTICS INC (BOLT:NASDAQ) percentage price change since previous trading day?
The percentage price change of BOLT BIOTHERAPEUTICS INC (BOLT:NASDAQ) since the previous trading day is 3.0214%.
What is the most recent average sentiment score for BOLT BIOTHERAPEUTICS INC (BOLT:NASDAQ)?
The most recent average sentiment score for BOLT BIOTHERAPEUTICS INC (BOLT:NASDAQ) is 43 out of 100.
What is the most recent average sentiment for BOLT BIOTHERAPEUTICS INC (BOLT:NASDAQ)?
The most recent sentiment for BOLT BIOTHERAPEUTICS INC (BOLT:NASDAQ) is .
SEC-8K** Filing Available For BOLT BIOTHERAPEUTICS INC (BOLT:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.